Financing channel feed – Endpoints News

Financing channel feed

Immunology startup RayThera secures $110M in Series A raise

Last month

ADC startup DualityBio seeks Hong Kong IPO amid precarious market

Last month

PIPEs, biopharma’s favorite financing vehicle, freeze amid market struggles

Last month

Exclusive: Daymark Health launches with $11.5M to care for cancer patients

Last month

Exclusive: Neurona bags $102M to treat epilepsy with cell therapy

Last month

Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy

2 months ago

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

2 months ago

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

2 months ago

Exclusive: SV Health debuts Parkinson's biotech with backing from AbbVie and others

2 months ago

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

2 months ago

Ophthalmology startup Character Biosciences gets $93M for genetics-based approach

2 months ago

Another immunology biotech emerges as Hillstar takes flight with $67M

2 months ago

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

2 months ago

23andMe files for bankruptcy, CEO Wojcicki steps down

2 months ago

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

2 months ago

SV Health Investors nabs $250M to fund dementia-focused biotechs

2 months ago

Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO

2 months ago

Flagship's Ampersand gets Eli Lilly's support in $65M Series B

2 months ago

A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

2 months ago

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

2 months ago

Sofinnova Partners lands €165M, backed by big pharma, to build early-stage biotechs in Europe

2 months ago

Curevo gets $110M for a shot against Shingrix, gets Moncef Slaoui and Tal Zaks on board

2 months ago

Latigo collects $150M to get non-opioid data to compete with Vertex in acute pain

2 months ago

Lilly-backed UK biotech raises $72M to advance its antibody approach

2 months ago

First page Previous page 1 234 5 6 Next page Last page